[Levamisole and thyroid diseases].
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D013956:Antithyroid Agents / Q000008:administration & dosage; D002648:Child; D006111:Graves Disease / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000096:biosynthesis; D007075:Immunoglobulin M / Q000096:biosynthesis; D007978:Levamisole / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008213:Lymphocyte Activation / Q000187:drug effects; D051379:Mice; D013601:T-Lymphocytes / Q000187:drug effects; D013959:Thyroid Diseases / Q000188:drug therapy* / Q000276:immunology
D013956:Antithyroid Agents; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007978:Levamisole
Levamizol i zabolevaniia shchitovidnoĭ zhelezy.